Previous Close | 0.3500 |
Open | 0.3450 |
Bid | 0.3300 x 0 |
Ask | 0.3350 x 0 |
Day's Range | 0.3350 - 0.3450 |
52 Week Range | 0.2300 - 0.4500 |
Volume | |
Avg. Volume | 68,446 |
Market Cap | 46.035M |
Beta (5Y Monthly) | 0.25 |
PE Ratio (TTM) | 11.17 |
EPS (TTM) | 0.0300 |
Earnings Date | Aug 08, 2024 - Aug 12, 2024 |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Sept 02, 1999 |
1y Target Est | N/A |
Reports results for its second quarter and first half of fiscal 2024 ended March 31. Q2 revenue was ...
Revenues of $5.6 million and Net Income of $0.4 millionMISSISSAUGA, Ontario, May 15, 2024 (GLOBE NEWSWIRE) -- Microbix Biosystems Inc. (TSX: MBX, OTCQX: MBXBF, Microbix®), a life sciences innovator, manufacturer, and exporter, reports results for its second quarter and first half of fiscal 2024 ended March 31, 2024 (“Q2” and “H1”), with strong growth in sequential and year-over-year quarterly revenues, reflective of ongoing progress to increase sales from its diagnostic-test related ingredients
With its stock down 12% over the past three months, it is easy to disregard Microbix Biosystems (TSE:MBX). However...